Assessing the Dual Activity of a Chalcone-Phthalocyanine Conjugate: Design, Synthesis, and Antivascular and Photodynamic Properties - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Molecular Pharmaceutics Année : 2013

Assessing the Dual Activity of a Chalcone-Phthalocyanine Conjugate: Design, Synthesis, and Antivascular and Photodynamic Properties

Laetitia L. Delort
Hermine H. Billard
  • Fonction : Auteur
  • PersonId : 1017645
Virginie Dubois
  • Fonction : Auteur
  • PersonId : 770782
  • IdRef : 19149058X

Résumé

Photodynamic therapy (PDT) and vascular-disrupting agents (VDA) each have their advantages in the treatment of solid tumors, but also present drawbacks. In PDT, hypoxia at the center of the tumor limits conversion of molecular oxygen into singlet oxygen, while VDAs are deficient at affecting the rim of the tumor. A phthalocyanine-chalcone conjugate combining the VDA properties of chalcones with the PDT properties of phthalocyanines was designed to address these deficiencies. Its vascular targeting, photophysical, photochemical, photodynamic activities are reported herein.
Fichier non déposé

Dates et versions

hal-02647780 , version 1 (29-05-2020)

Identifiants

Citer

Sinem Tuncel, Aurélien Trivella, Devrim Atilla, Khalil Bennis, Huguette Savoie, et al.. Assessing the Dual Activity of a Chalcone-Phthalocyanine Conjugate: Design, Synthesis, and Antivascular and Photodynamic Properties. Molecular Pharmaceutics, 2013, 10 (10), pp.3706 - 3716. ⟨10.1021/mp400207v⟩. ⟨hal-02647780⟩
113 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More